trump glp-1 pilot program Novo Nordisk, Lilly strike deal with to slash weight-loss drug prices The Trump Administration is delivering

Science 375 , 9196 (2022)

BPC-157 (Body Protection Compound) w rodowisku naukowym znany jest z unikalnej zdolnoci do drastycznego przyspieszania gojenia tkanek mikkich (cigien, wizade), a take regeneracji nabonka jelitowego

If you have NASH without diabetes or obesity, approval requires submitting a prior authorization with: Biopsy or imaging confirmation of NASH with fibrosis stage F2 or higher Documentation of failed standard treatments (vitamin E, pioglitazone, lifestyle modification for at least 6 months) Peer-reviewed evidence supporting GLP-1 use in NASH A letter of medical necessity from a hepatologist or gastroenterologist Approval rate: 15-25% on first submission, 30-40% after appeal with additional specialist documentation

While semaglutide is generally well tolerated, some people experience mild to moderate side effects such as nausea, vomiting, diarrhea, constipation, or abdominal discomfortsymptoms that often improve as your body adjusts to the medication